Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Sympathomimetic with alpha adrenergic activity. It has vasoconstrictor effect that reduces edema and mucosal congestion. Topical nasal or ophthalmologic use (2 - 3 times a day).
At the date of last update we found no published data in relation to breastfeeding.
The small dose and the low plasmatic absorption of most nasal or ophthalmologic topical preparations make unlikely the passage of significant amount into breast milk.
Do not exceed recommended doses and time to avoid undesirable side effects and the possible decrease in milk cited by some authors (Nice 2000) for other similar drugs, although not proven in practice.
Product with very few bibliographic references and almost none on pharmacokinetics. As a nasal decongestant it is not recommended by some authors (Nice 2000), being preferable drugs of the same group better known. (Anderson 2000)
Ophthalmic administration is totally compatible with breastfeeding. Absorption can be minimized by pressing with the finger on the tear duct (inner canthus of the eye) for 1 minute.
Some authors consider oral and nasal decongestant drugs dispensable medications, to be avoided in general, not only during breastfeeding, as they expose patients to serious risks (cardiovascular, neurological and intestinal) to treat a benign alteration such as nasal obstruction, which usually evolves favorably in a few days without medication. (Prescrire 2018)
In 2025 a mother wrote to us: “only used once before bedtime at night for two days and decreased breast milk is appreciated and the baby sleeps worse, possible insomnia”.